Course Details

Biotechnological drugs, toxicology and pharmacogenetics

MS1856

Course
Biotechnological drugs, toxicology and pharmacogenetics
Code
MS1856
Academic Year
2026/2027
Curriculum Year
2024/2025
Degree Programme
BIOTECHNOLOGY
Curriculum
A003 - BIOTECNOLOGICO CHIMICO-FARMACEUTICO
Course coordinator
Credits
13
Lecture Hours
104
Scientific Disciplinary Sector (SSD)
BIO/14 - Pharmacology
Course Type
Single-subject learning activity
Course Delivery
OBB - Obbligatoria
Year
3
Teaching period
Secondo Semestre
Campus
NOVARA
Teaching language
Italian
Course Contents
The course will focus on basic pharmacology (how a drug affects the body and how the body affects the drug) and pharmacotherapy, with a focus on biotechnological drugs and advanced therapies.
Reference Texts
1) Rossi, Cuomo - Farmacologia; 2) Katzung, Vanderah - Farmacologia generale e clinica 3) MORE COMPLICATED TEXT:Goodman and Gilman, Basi di Farmacologia (to be consulted in the library) 3) scientific literature; 4) documents on the EMA and FDA website
Learning Outcomes
1) introduction to the general principles of pharmacology;
2) Define the peculiarities of biotech and advanced products compared to traditional drugs;
3) Illustrate the process of pharmaceutical R&D with examples;
4) Provide intellectual instruments to the student to define a rationale drug discovery program;
Prerequisites
To fully learn the subject it is necessary to know:
- organic chemistry;
- biochemistry;
- physiology;
- pathology.
Teaching Methods
traditional lectures and reading material on the course website. The course will be interspersed with a practical laboratory session and group work.
Additional Information
The course will take place in the second semester.
Assessment Methods
The exam consists of a written test with multiple choice questions and open questions, for a total of 31 points.
Detailed Syllabus
Drug development: preclinical and clinical phases
Pharmacodynamics: receptors and signal transduction; concepts of agonists and antagonists; dose-response curves.
Pharmacokinetics: drug absorption, distribution, metabolism, and excretion.
Pharmacogenetics and toxicology.
Neurotransmission: pharmacological tools.
Biotech drugs: therapeutic proteins, monoclonal antibodies, vaccines.

Drugs for inflammation and pain: NSAIDs, glucocorticoids, opioids.
Chemotherapeutic agents (antibacterial and oncological).
Cardiovascular drugs: antiarrhythmics, drugs for heart failure, antithrombotics, anticoagulants, and fibrinolytics.
Antidyslipidemic drugs.
Diabetes medications: insulin, oral hypoglycemic agents, and newer therapies.
- Drugs acting on the nervous system: drugs for Parkinson's disease, antidepressants, anxiolytics, sedative-hypnotics, antiepileptics.
Respiratory system drugs.
Antineoplastic drugs: conventional chemotherapy, targeted therapy, and immunotherapy.
Expected Learning Outcomes
The aim of the course is to provide to the Biology student a basis of general pharmacology applied to clinical practice. Briefly, the knowledge of the concepts of agonism and antagonism, of substitutive, etiological and symptomatic drugs, in parallel with the knowledge of the causes of a pathology, will allow the students to understand the right therapy. Furthermore, the knowledge of biological targets, where they are expressed in the body and of which drugs are them the target, can allow to understand also the adverse effects of drugs in therapy. At the end of the course, the student will acquire a scientific language and will know how to use the correct terms to indicate the action of a drug.
In the event that the student was interested, this course can also provide the basis for approaching pre-clinical scientific research.
Last update:09-09-2026 00:14:31